Malaria protein kinase CK2 (PfCK2) shows novel mechanisms of regulation

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Graciotti, Michele ^a   Alam, Mahmood ^a   Solyakov, Lev ^a   Schmid, Ralf ^a   Burley, Glenn ^b   Bottrill, Andrew R ^a   Doerig, Christian ^c   Cullis, Paul ^a   Tobin, Andrew B ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^c MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CASEIN KINASE II; QUINALIZARIN; THREONINE; TYROSINE; 1,2,5,8-TETRAHYDROXY ANTHRAQUINONE; ADENOSINE TRIPHOSPHATE; ANTHRAQUINONE DERIVATIVE; PROTOZOAL PROTEIN;

ARTICLE; AUTOPHOSPHORYLATION; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; ENZYME SPECIFICITY; ENZYME STRUCTURE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMODIUM FALCIPARUM; PROTEIN DOMAIN; REGULATORY MECHANISM; AMINO ACID SEQUENCE; BINDING SITE; BIOLOGY; CHEMICAL STRUCTURE; CHEMISTRY; ENZYMOLOGY; HUMAN; METABOLISM; MOLECULAR GENETICS; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE;

ADENOSINE TRIPHOSPHATE; AMINO ACID SEQUENCE; ANTHRAQUINONES; BINDING SITES; CASEIN KINASE II; COMPUTATIONAL BIOLOGY; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PLASMODIUM FALCIPARUM; PROTEIN STRUCTURE, TERTIARY; PROTOZOAN PROTEINS;

EID: 84899108210     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085391     Document Type: Article

References (44)

1. Johnson LN (2009) Protein kinase inhibitors: contributions from structure to clinical compounds. Q Rev Biophys 42: 1-40.
2. Zhang J, Yang PL and Gray NS (2009) Targeting cancer with small molecule kinase inhibitors. Nat Rev Cancer 9: 28-39.
3. Lucet IS, Tobin A, Drewry D, Wilks AF, Doerig C (2012) Plasmodium kinases as targets for new-generation antimalarials. Future medicinal chemistry 4: 2295-2310.
4. Talevich E, Tobin AB, Kannan N, Doerig C (2012) An evolutionary perspective on the kinome of malaria parasites. Philosophical transactions of the Royal Society of London Series B, Biological sciences 367: 2607-2618.
5. Ward P, Equinet L, Packer J, Doerig C (2004) Protein kinases of the human malaria parasite Plasmodium falciparum: the kinome of a divergent eukaryote. BMC genomics 5: 79.
6. Meggio F, Pinna LA (2003) One-thousand-and-one substrates of protein kinase CK2? FASEB journal : official publication of the Federation of American Societies for Experimental Biology 17: 349-368.
7. Litchfield DW (2003) Protein kinase CK2: structure, regulation and role in cellular decisions of life and death. The Biochemical journal 369: 1-15.
8. Holland Z, Prudent R, Reiser JB, Cochet C, Doerig C (2009) Functional analysis of protein kinase CK2 of the human malaria parasite Plasmodium falciparum. Eukaryot Cell 8: 388-397.
9. Dastidar EG, Dayer G, Holland ZM, Dorin-Semblat D, Claes A, et al. (2012) Involvement of Plasmodium falciparum protein kinase CK2 in the chromatin assembly pathway. BMC biology 10: 5.
10. Chenna R, Sugawara H, Koike T, Lopez R, Gibson TJ, et al. (2003) Multiple sequence alignment with the Clustal series of programs. Nucleic acids research 31: 3497-3500. (Pubitemid 37442184)
11. Fiser A, Sali A (2003) Modeller: generation and refinement of homology-based protein structure models. Methods in enzymology 374: 461-491. (Pubitemid 37531821)
12. Niefind K, Guerra B, Ermakowa I, Issinger OG (2001) Crystal structure of human protein kinase CK2: insights into basic properties of the CK2 holoenzyme. The EMBO journal 20: 5320-5331. (Pubitemid 32959451)
13. Cozza G, Mazzorana M, Papinutto E, Bain J, Elliott M, et al. (2009) Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2. The Biochemical journal 421: 387-395.
14. Lasonder E, Green JL, Camarda G, Talabani H, Holder AA, et al. (2012) The Plasmodium falciparum schizont phosphoproteome reveals extensive phosphatidylinositol and cAMP-protein kinase A signaling. Journal of proteome research 11: 5323-5337.
15. Solyakov L, Halbert J, Alam MM, Semblat JP, Dorin-Semblat D, et al. (2011) Global kinomic and phospho-proteomic analyses of the human malaria parasite Plasmodium falciparum. Nat Commun 2: 565.
16. Treeck M, Sanders JL, Elias JE, Boothroyd JC (2011) The phosphoproteomes of Plasmodium falciparum and Toxoplasma gondii reveal unusual adaptations within and beyond the parasites' boundaries. Cell host & microbe 10: 410-419.
17. Donella-Deana A, Cesaro L, Sarno S, Brunati AM, Ruzzene M, et al. (2001) Autocatalytic tyrosine-phosphorylation of protein kinase CK2 alpha and alpha' subunits: implication of Tyr182. The Biochemical journal 357: 563-567. (Pubitemid 32701796)
18. Tewari R, Straschil U, Bateman A, Bohme U, Cherevach I, et al. (2010) The systematic functional analysis of Plasmodium protein kinases identifies essential regulators of mosquito transmission. Cell host & microbe 8: 377-387.
19. Leroy D, Doerig C (2008) Drugging the Plasmodium kinome: the benefits of academia-industry synergy. Trends Pharmacol Sci 29: 241-249.
20. Doerig C, Abdi A, Bland N, Eschenlauer S, Dorin-Semblat D, et al. (2010) Malaria: targeting parasite and host cell kinomes. Biochimica et biophysica acta 1804: 604-612.
21. Manning G, Plowman GD, Hunter T, Sudarsanam S (2002) Evolution of protein kinase signaling from yeast to man. Trends in biochemical sciences 27: 514-520. (Pubitemid 35279596)
22. Manning G, Young SL, Miller WT, Zhai Y (2008) The protist, Monosiga brevicollis, has a tyrosine kinase signaling network more elaborate and diverse than found in any known metazoan. Proceedings of the National Academy of Sciences of the United States of America 105: 9674-9679. (Pubitemid 352031359)
23. Shiu SH, Li WH (2004) Origins, lineage-specific expansions, and multiple losses of tyrosine kinases in eukaryotes. Molecular biology and evolution 21: 828-840.
24. Nett IR, Martin DM, Miranda-Saavedra D, Lamont D, Barber JD, et al. (2009) The phosphoproteome of bloodstream form Trypanosoma brucei, causative agent of African sleeping sickness. Molecular & cellular proteomics : MCP 8: 1527-1538.
25. Parsons M, Worthey EA, Ward PN, Mottram JC (2005) Comparative analysis of the kinomes of three pathogenic trypanosomatids: Leishmania major, Trypanosoma brucei and Trypanosoma cruzi. BMC genomics 6: 127.
26. Manning G, Reiner DS, Lauwaet T, Dacre M, Smith A, et al. (2011) The minimal kinome of Giardia lamblia illuminates early kinase evolution and unique parasite biology. Genome biology 12: R66.
27. Peixoto L, Chen F, Harb OS, Davis PH, Beiting DP, et al. (2010) Integrative genomic approaches highlight a family of parasite-specific kinases that regulate host responses. Cell host & microbe 8: 208-218.
28. Holt LJ, Tuch BB, Villen J, Johnson AD, Gygi SP, et al. (2009) Global analysis of Cdk1 substrate phosphorylation sites provides insights into evolution. Science 325: 1682-1686.
29. Parsons M, Valentine M, Carter V (1993) Protein kinases in divergent eukaryotes: identification of protein kinase activities regulated during trypanosome development. Proceedings of the National Academy of Sciences of the United States of America 90: 2656-2660. (Pubitemid 23113475)
30. Pease BN, Huttlin EL, Jedrychowski MP, Talevich E, Harmon J, et al. (2013) Global Analysis of Protein Expression and Phosphorylation of Three Stages of Plasmodium falciparum Intraerythrocytic Development. Journal of proteome research 12: 4028-4045.
31. Pantaleo A, Ferru E, Carta F, Mannu F, Giribaldi G, et al. (2010) Analysis of changes in tyrosine and serine phosphorylation of red cell membrane proteins induced by P. falciparum growth. Proteomics 10: 3469-3479.
32. Low H, Chua CS, Sim TS (2012) Plasmodium falciparum possesses a unique dual-specificity serine/threonine and tyrosine kinase, Pfnek3. Cellular and molecular life sciences : CMLS 69: 1523-1535.
33. Lasonder E, Treeck M, Alam M, Tobin AB (2012) Insights into the Plasmodium falciparum schizont phospho-proteome. Microbes and infection/Institut Pasteur 14: 811-819.
34. Aranda S, Laguna A, de la Luna S (2011) DYRK family of protein kinases: evolutionary relationships, biochemical properties, and functional roles. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 25: 449-462.
35. Lochhead PA (2009) Protein kinase activation loop autophosphorylation in cis: overcoming a Catch-22 situation. Science signaling 2: pe4.
36. Lochhead PA, Kinstrie R, Sibbet G, Rawjee T, Morrice N, et al. (2006) A chaperone-dependent GSK3beta transitional intermediate mediates activation-loop autophosphorylation. Mol Cell 24: 627-633. (Pubitemid 350284229)
37. Gazarini ML, Garcia CR (2003) Interruption of the blood-stage cycle of the malaria parasite, Plasmodium chabaudi, by protein tyrosine kinase inhibitors. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas/Sociedade Brasileira de Biofisica [et al] 36: 1465-1469.
38. Mishra NC, Sharma M, Sharma A (1999) Inhibitory effect of piceatannol, a protein tyrosine kinase inhibitor, on asexual maturation of Plasmodium falciparum. Indian journal of experimental biology 37: 418-420. (Pubitemid 29180679)
39. Trembley JH, Wang G, Unger G, Slaton J, Ahmed K (2009) Protein kinase CK2 in health and disease: CK2: a key player in cancer biology. Cellular and molecular life sciences : CMLS 66: 1858-1867.
40. Ahmad KA, Wang G, Slaton J, Unger G, Ahmed K (2005) Targeting CK2 for cancer therapy. Anti-cancer drugs 16: 1037-1043. (Pubitemid 41565768)
41. Pagano MA, Andrzejewska M, Ruzzene M, Sarno S, Cesaro L, et al. (2004) Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7- tetrabromobenzimidazole. Journal of medicinal chemistry 47: 6239-6247. (Pubitemid 39587248)
42. Sarno S, de Moliner E, Ruzzene M, Pagano MA, Battistutta R, et al. (2003) Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA). The Biochemical journal 374: 639-646. (Pubitemid 37163909)
43. Pierre F, Chua PC, O'Brien SE, Siddiqui-Jain A, Bourbon P, et al. (2011) Preclinical characterization of CX-4945, a potent and selective small molecule inhibitor of CK2 for the treatment of cancer. Molecular and cellular biochemistry 356: 37-43.
44. Siddiqui-Jain A, Drygin D, Streiner N, Chua P, Pierre F, et al. (2010) CX-4945, an orally bioavailable selective inhibitor of protein kinase CK2, inhibits prosurvival and angiogenic signaling and exhibits antitumor efficacy. Cancer research 70: 10288-10298.